ligands, the expectation is that they will only trigger G-protein–independent pathways that promote antiremodeling and bronchorelaxant actions via b -arrestin pathways that are distinct from those driving bronchial hyperresponsiveness. The… Click to show full abstract
ligands, the expectation is that they will only trigger G-protein–independent pathways that promote antiremodeling and bronchorelaxant actions via b -arrestin pathways that are distinct from those driving bronchial hyperresponsiveness. The study by Tompkins provides strong evidence for a therapeutic role of some of the M3 AChR-associated b -arrestin pathways that remain to be further investigated (?). GPCR=G-protein coupled receptor; GRKs=GPCR kinases; P=phosphorylation site; PLC=phospholipase.
               
Click one of the above tabs to view related content.